The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma

被引：0
|
作者：
Zhou, Lijun [1 ]
Liu, Xiande [1 ]
Sun, Mianen [1 ]
Tannir, Nizar M. [1 ]
Laird, Douglas [2 ]
Jonasch, Eric [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Exelixis Inc, San Francisco, CA USA
来源：
ANGIOGENESIS | 2014年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P-128
引用
收藏
页码：774 / 774
页数：1
相关论文
共 50 条
  • [1] The mechanisms of anti-VEGF therapy resistance in renal cell carcinoma
    Zhou, Lijun
    Liu, Xiande
    Sun, Mianen
    Tannir, Nizar M.
    Laird, Douglas
    Jonasch, Eric
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma
    Escudier, Bernard
    Cosaert, Jan
    Pisa, Pavel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1545 - 1557
  • [3] Acute nephritic syndrome after anti-VEGF therapy for renal cell carcinoma
    Rolleman, Edgar J.
    Weening, Jan
    Betjes, Michiel G. H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) : 2002 - 2003
  • [4] Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma
    Roncone, Daniel
    Satoskar, Anjali
    Nadasdy, Tibor
    Monk, J. Paul
    Rovin, Brad H.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (05): : 287 - 293
  • [5] Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma
    Daniel Roncone
    Anjali Satoskar
    Tibor Nadasdy
    J Paul Monk
    Brad H Rovin
    Nature Clinical Practice Nephrology, 2007, 3 : 287 - 293
  • [6] Mechanisms of Resistance to anti-VEGF Therapy in Patients with Ovarian Cancer
    Hladchenko, L.
    Kessler, M.
    Hierlmayer, S.
    Reichenbach, J.
    Kraus, F.
    Czogalla, B.
    Burges, A.
    Mayr, D.
    Mahner, S.
    Trillsch, F.
    Chelariu-Raicu, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2024, 84 (06) : E40 - E40
  • [7] Anti-VEGF therapy in pituitary carcinoma
    Ortiz, Leon D.
    Syro, Luis V.
    Scheithauer, Bernd W.
    Ersen, Ayca
    Uribe, Humberto
    Fadul, Camilo E.
    Rotondo, Fabio
    Horvath, Eva
    Kovacs, Kalman
    PITUITARY, 2012, 15 (03) : 445 - 449
  • [8] Anti-VEGF therapy in pituitary carcinoma
    Leon D. Ortiz
    Luis V. Syro
    Bernd W. Scheithauer
    Ayca Ersen
    Humberto Uribe
    Camilo E. Fadul
    Fabio Rotondo
    Eva Horvath
    Kalman Kovacs
    Pituitary, 2012, 15 : 445 - 449
  • [9] Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases
    Sharma, Dhyana
    Zachary, Ian
    Jia, Haiyan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (05) : 28
  • [10] Endothelial fenestration of tumour microvasculature as a predictive factor of ANTI-VEGF therapy in clear cell renal cell carcinoma
    Yamasaki, T.
    Kamba, T.
    Nakamura, E.
    Kanno, T.
    Kamoto, T.
    Ogawa, O.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 98 - 98
12345